[VRTX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
14-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 197.80%
YoY- 205.61%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,627,820 1,413,265 870,106 651,634 458,706 417,935 144,556 49.65%
PBT 888,623 676,950 32,497 112,442 20,306 -77,829 -178,594 -
Tax 284,433 93,716 -1,492,599 10,257 -7,453 -1,379 2,043 127.48%
NP 604,190 583,234 1,550,527 100,684 32,945 -75,512 -176,656 -
Tax Rate -32.01% -13.84% 4,593.04% -9.12% 36.70% - - -
Total Cost 1,023,630 830,031 -680,421 550,950 425,761 493,447 321,212 21.28%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 37.12 41.27 178.20 15.45 7.18 -18.07 -122.21 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 2.32 2.26 6.08 0.40 0.13 -0.31 -0.74 -
EPS Diluted 2.30 2.23 5.97 0.39 0.13 -0.31 -0.74 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.